全球基因重組技術市場按產品類型、應用、最終用戶和地區分類

2025 年全球重組基因技術市場價值估計為 1,899.1 億美元，預計到 2032 年將達到 3,656.2 億美元，2025 年至 2032 年的複合年成長率為 9.8%。

數字。 2025 年基因工程技術市場佔有率（%），依地區分類

重組基因工程涉及將來自兩個不同來源的 DNA 分子組合成一個分子，該分子可以指導其自身構建塊和相關蛋白質的複製和組裝。這個過程涉及透過使用限制酶、DNA連接酶和逆轉錄酶將兩條不同的 DNA 鏈物理連接和交織在一起。最近的進展表明，重組基因技術是遺傳學和生物技術領域的革命性進步，其應用範圍廣泛，包括藥物開發、研究和農業。與傳統萃取方法相比，該技術可以生產出更大量的人類蛋白質和藥物。它也被用於開發目前無法治癒的疾病的新治療方法以及提高農作物產量。由於各行業的需求不斷增加，重組基因技術市場預計未來幾年將大幅成長。

市場動態：

重組基因技術市場受到多種因素的推動，包括製藥和生物技術行業研發活動的增加、慢性病盛行率的上升以及對基因工程和基因治療的需求不斷成長。此外，對經濟實惠的醫療保健和治療解決方案的需求，加上 DNA 分析和定序技術的技術進步，正在推動市場成長。然而，高成本和嚴格的臨床試驗規定可能會限制市場的成長。此外，圍繞生殖系基因編輯的倫理問題可能會阻礙市場擴張。另一方面，新興市場醫療支出的增加為主要企業提供了有利可圖的機會。此外，隨著基改作物在農業上的應用越來越廣泛，預計未來幾年將創造新的收益來源。

本研究的主要特點

• 本報告對全球重組基因技術市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 報告根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球重組基因技術市場的主要企業進行了概述。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球重組基因技術市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員可以透過用於分析全球基因改造技術市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 最新動態
• 監管情景
• 技術進步
• 製造商收益
• 收購和合作場景
• 產品發布/核准
• 資金籌措和投資
• PEST分析
• 波特的分析

第 4 章 全球基因改造技術市場：COVID-19 疫情的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 全球基因改造技術市場依產品類型分類（2020-2032 年）

• 重組蛋白藥物
• 疫苗
• 基因改造作物
• 細胞和基因治療
• 基因編輯

6. 全球基因改造技術市場按應用分類（2020-2032 年）

• 治療
• 農業
• 研究
• 其他

7. 全球基因改造技術市場（按最終用戶分類） (2020-2032)

• 生技及製藥公司
• 診斷實驗室
• 學術和政府實驗室
• 其他

8. 全球基因改造技術市場（按地區分類） (2020-2032)

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • Thermo Fisher Scientific, Inc.
  • Biogen, Inc.
  • Sanofi
  • Pfizer, Inc.
  • Amgen, Inc.
  • Merck &Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

第 10 章 分析師觀點

• 命運之輪
• 分析師觀點
• Coherent Opportunity Map（COM）

第 11 章 參考文獻與調查方法

• 參考
• 調查方法

Global Recombinant Dna Technology Market is estimated to be valued at USD 189.91 Bn in 2025 and is expected to reach USD 365.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Figure. Recombinant Dna Technology Market Share (%), By Region 2025

Recombinant DNA technology is the joining together of DNA molecules from two different sources into one molecule that can replicate and direct the assembly of its own components or related proteins. This process involves physically combining and interweaving two different strands of DNA through the use of restriction enzymes, DNA ligases and reverse transcriptase. In recent years, recombinant DNA technology has proven to be a revolutionary advancement in the field of genetics and biotechnology with wide ranging applications in drug development, research, and agriculture. This technology allows for the production of human proteins and medicines in much larger quantities than traditional extraction methods. It is also being used to develop new treatments for currently incurable diseases and to enhance crop yields. With growing demand across industries, the recombinant DNA technology market is poised to grow significantly in the coming years.

Market Dynamics:

The recombinant DNA technology market is driven by several factors such as increasing R&D activities in pharmaceutical and biotech industries, rising prevalence of chronic diseases, growing demand for genetic engineering, and gene therapy. The demand for affordable healthcare and therapeutic solutions combined with technological advancements in DNA analysis and sequencing techniques are also fueling the market growth. However, the market growth can be restricted due to high costs associated with development and stringent regulations for clinical trials. Moreover, ethical issues regarding germline gene editing may hamper market expansion to some extent. On the flip side, rising healthcare expenditures in emerging nations offer lucrative opportunities for key players. In addition, the growing acceptance of genetically modified crops for agriculture applications is expected to create new revenue pockets in the forthcoming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global recombinant DNA technology market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global recombinant DNA technology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi , Pfizer, Inc., Amgen, Inc., Merck & Co., Inc., Profacgen, Monsanto Company, Genentech Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., GSK plc., Jiangsu Recbio Technology Co., Ltd., New England Biolabs, GenScript, Lonza, and ProteoGenix.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global recombinant DNA technology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant DNA technology market.

Detailed Segmentation-

• By Product Type:
  • Recombinant Protein Drugs
  • Vaccines
  • Genetically Modified Crops
  • Cell and Gene Therapy
  • Gene Editing
• By Application:
  • Therapeutics
  • Agriculture
  • Research
  • Others
• By End User:
  • Biotechnology and Pharmaceutical Company
  • Diagnostic Laboratories
  • Academic and Government Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • Biogen, Inc.
  • Sanofi
  • Pfizer, Inc.
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Regulatory Scenario
• Technological Advancements
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Recombinant DNA Technology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Recombinant DNA Technology Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Recombinant Protein Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetically Modified Crops
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell and Gene Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Editing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Recombinant DNA Technology Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Agriculture
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Recombinant DNA Technology Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Biotechnology and Pharmaceutical Company
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Government Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Recombinant DNA Technology Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Biogen, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"